FDA — authorised 18 October 1979
- Application: NDA018116
- Marketing authorisation holder: ASTELLAS
- Local brand name: CYCLOCORT
- Indication: CREAM — TOPICAL
- Status: approved
FDA authorised Cyclocort on 18 October 1979
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 18 October 1979; FDA authorised it on 13 November 1981; FDA authorised it on 13 June 1988.
ASTELLAS holds the US marketing authorisation.